Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,128 | Dovepress* | 10,697+ | 1,644 | 12,341 | |
| PubMed Central* | 3,431 | 775 | 4,206 | ||
| Totals | 14,128 | 2,419 | 16,547 | ||
| *Since 14 November 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar